A bereaved mother welcomes a bold investment in brain cancer research as plans move forward for a new university centre. Brain Tumour Research has committed £2.6 million to create a centre of excellence at the University of Nottingham, dedicated to deepening our understanding of glioblastoma and improving treatment options. The charity’s aim is clear: to pursue a cure for the deadliest form of adult brain tumour.
Maggie Cullen of Boston, who lost her son Josh to glioblastoma in October last year, expressed her support: “If scientists and doctors can find a cure and spare other mums the agony of watching their children suffer, it would be nothing short of a miracle.” Josh, who loved aviation and had hoped to move to Canada, received his diagnosis on Christmas Eve 2020 at age 24.
When the diagnosis was revealed, Maggie recalled the sting of the word, saying, “Glioblastoma” was the last thing a parent wants to hear. The prognosis given for Josh was 12 to 18 months, and Maggie imagines herself in his shoes at 24, likely giving up. But Josh remained resilient and determined.
The Nottingham centre’s strategy includes leveraging artificial intelligence and cutting-edge MRI imaging to detect tumour recurrence earlier. Professor Ruman Rahman, the centre’s principal investigator, outlined a vision where brain imaging could ultimately guide personalized drug choices to prevent recurrence. He cautioned that such a transformation will take time and sustained funding to move from discovery to clinical practice, with the ultimate goal of curing brain tumours becoming a reality.
Ms. Cullen expressed relief and optimism that meaningful progress is finally underway in research that touches so many people. “Brain tumour research is incredibly important to so many families,” she said.
The initiative has also been welcomed by glioblastoma patients themselves, including Verity Phillips, a 35-year-old mother of four from Immingham, who was diagnosed with glioblastoma in 2022 after a collapse. She reflected on the brutality of the disease and the grim early prognosis, noting that she has surpassed those initial odds but remains vigilant, living from scan to scan.
“Glioblastoma is brutal,” Phillips said. “I want to be here for all the bedtime cuddles, the silly arguments, and everything in between.” She sees the Nottingham centre as a beacon of hope for patients like her, pledging to continue raising awareness and supporting research until a cure is found.
Listeners can catch highlights from Lincolnshire on BBC Sounds, watch the latest Look North episode, or share another story idea for BBC coverage. For mobile access, the BBC News app is available on iPhone, iPad, and Android devices.
